Lisata Therapeutics
LSTA
LSTA
24 hedge funds and large institutions have $1.8M invested in Lisata Therapeutics in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% less capital invested
Capital invested by funds: $2.17M → $1.8M (-$379K)
Holders
24
Holding in Top 10
–
Calls
$202K
Puts
–
Top Buyers
| 1 | +$25.1K | |
| 2 | +$12.5K | |
| 3 | +$4K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.06K |
| 5 |
Morgan Stanley
New York
|
+$336 |
Top Sellers
| 1 | -$32.6K | |
| 2 | -$22.3K | |
| 3 | -$1.78K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$420 |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$160 |